Trader TV Watchlist - January 6, 2026

Tuesday January 6, 2026

Welcome to the TraderTV Live Morning Research Note. Here's what's making major moves in the market today.

TraderTV.LIVE™ features a daily live trading broadcast, professional education and an active community of more than 450,000 subscribers. Join us on YouTube every weekday from 8:30am to 4:30pm EST for the first and only professional trading show on YouTube Live!

Economic Events:

0800 - Fed’s Barkin
0945 - S&P composite PMI for December: Prior 53
0945 - S&P services PMI for December: Expected 52.9; Prior 52.9

Premarket Trading:

Trading Higher ($): ARBE, NVDA, SMR

Trading Lower ($): TSLA, RGTI, IREN

Earnings Today:

Premarket: ANGO

Post-market: AIR, PENG

In The News

Advanced Micro Devices Inc (AMD)

+0.71%

On watch following a keynote address from CEO Lisa Su at CES 2026. The company unveiled the MI440X aimed at smaller on-prem data centers and highlighted the MI455X alongside its Helios rack built on MI455 accelerators and EPYC Venice CPUs. Su also previewed the MI500 series for 2027, targeting roughly 1,000x performance gains versus the MI300.

NVIDIA Corp (NVDA)

+0.60%

During a keynote speech at CES 2026, CEO Jensen Huang announced that the company’s next-generation chips are in full production and offer five times the AI computing power of previous models for chatbots and other AI applications. The chips, already being tested by AI firms in Nvidia’s labs, are set to launch later this year amid growing competition from rivals and customers. BofA reiterated its Buy rating and $275 price target on the stock following the keynote.

Tesla Inc (TSLA)

-0.50%

Trading marginally lower premarket following another round of disappointing registration data out of Europe. The company’s UK vehicle registrations fell more than 29% year over year in December to 6,323 units, highlighting intensifying competition in one of its largest European markets. Meanwhile, the company’s full-year sales in Germany dropped by 48% on a year-over-year basis in 2025, even as overall EV registrations in Germany grew by 43.2%.

Intel Corp (INTC)

+0.99%

Trading higher premarket after launching Panther Lake, its new AI-focused laptop chip, at CES 2026. This marks the first high-volume product built on the next-generation 18A manufacturing process with a new transistor design and power delivery architecture. The debut is a critical test for Intel as it seeks to prove its 18A technology and regain market share lost to AMD.

Micron Technology Inc (MU)

+1.24%

Korean media outlet etnews reported that Micron plans to ramp HBM4 capacity to about 15,000 wafers per month this year, roughly 30% of its total HBM output. This update comes as Nvidia’s Vera Rubin platform enters production. The company reportedly said HBM4 volumes will begin ramping in Q2 and are expected to achieve faster yield improvements than HBM3E.

Palantir Technologies Inc (PLTR)

+0.61%

Trading marginally higher premarket after Truist initiated coverage on the stock with a Buy rating and $223. The analyst attributed the positive rating to Palantir’s strong positioning to drive GenAI adoption across government and enterprise customers. Truist highlighted the company’s accelerating revenue growth, expanding operating margins above 50%, and significant international growth potential as key drivers.

Apple Inc (AAPL)

-0.23%

On watch following a note from BofA, with the analyst noting that Apple posted its slowest quarterly revenue growth in roughly 11 quarters. However, the analyst acknowledged App Store trends remained healthy with fiscal 1Q26 revenue up 6.8% y/y, offset by weaker growth in China. The firm maintained a Buy and $325 price target, citing strong capital returns, expected leadership in on-device AI, and long-term optionality from new products and markets.

Super Micro Computer Inc (SMCI)

+1.63%

Trading higher premarket after announcing the expansion of its US-based manufacturing and liquid-cooling capabilities, partnering with Nvidia to accelerate deployment of AI data center solutions optimized for the Vera Rubin and Rubin platforms. Using its Data Center Building Block Solutions (DCBBS) approach, the company can deliver highly customizable, next-generation liquid-cooled AI infrastructure faster, giving customers a competitive edge.

Upstart Holdings Inc (UPST)

+1.34%

Truist Securities initiated coverage of the stock with a Buy rating and a $59 price target, highlighting its AI-driven underwriting platform that uses non-traditional data to improve credit risk assessment. The firm views Upstart as a leveraged play on easing U.S. interest rates and stabilizing or improving consumer credit, despite its sensitivity to the credit cycle. Upstart, which closed Monday’s session more than 10% higher, has a short float of approximately 27.1%.

D-Wave Quantum Inc (QBTS)

+0.46%

The company announced that it achieved a breakthrough in gate-model quantum computing by successfully demonstrating scalable on-chip cryogenic control of qubits. This industry-first milestone reduces the wiring needed to manage large qubit arrays while maintaining fidelity, advancing the development of commercially viable quantum computers. Approximately 12.4% of the stock’s float is sold short.

Vistra Corp (VST)

+4.61%

Trading sharply higher premarket after announcing an agreement to acquire Cogentrix Energy’s portfolio of 10 natural gas–fired power plants from Quantum Capital for about $4.7 billion. The deal, which follows Vistra’s $1.9 billion gas-plant acquisition in May 2025, includes cash, stock, and assumed debt and further expands its natural gas generation footprint.

Bright Minds Biosciences Inc (DRUG)

+6.24%

Gapping up after reporting positive Phase 2 results for BMB-101 in drug-resistant epilepsy, with median absence seizures down 73.1% in 11 evaluable patients and major motor seizures down 63.3% in 6 evaluable developmental/encephalopathic epilepsy patients. Of 24 patients, 18 completed maintenance, and no treatment-related serious adverse events were observed.

Cyclerion Therapeutics Inc (CYCN)

+49.28%

Gapping up after announcing an exclusive collaboration with Medsteer to integrate Medsteer’s closed-loop anesthetic delivery technology into Cyclerion’s lead program, CYC-126, aimed at treating treatment-resistant depression (TRD). The partnership seeks to advance CYC-126’s precision anesthetic-based therapy, with a Phase 2 proof-of-concept study planned for 2026. The stock has a market capitalization of $5.42 million and a float of 2.31 million shares.